Spots Global Cancer Trial Database for auto stem cell transplant
Every month we try and update this database with for auto stem cell transplant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients | NCT01402284 | Multiple Myelom... | Carfilzomib Lenalidomide Dexamethasone Lenalidomide Lenalidomide | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma | NCT01241708 | Multiple Myelom... Auto Stem Cell ... | Bortezomib | 18 Years - 75 Years | Hackensack Meridian Health | |
Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma | NCT01468311 | Hodgkin Disease Hodgkin Lymphom... | Auto stem cell ... BEAM 111In-daclizuma... 90Y-daclizumab | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma | NCT01468311 | Hodgkin Disease Hodgkin Lymphom... | Auto stem cell ... BEAM 111In-daclizuma... 90Y-daclizumab | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma | NCT01241708 | Multiple Myelom... Auto Stem Cell ... | Bortezomib | 18 Years - 75 Years | Hackensack Meridian Health |